Raymond Dennis Pratt - 03 May 2021 Form 4 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Jun 2021, 16:49:12 UTC
Next SEC filing
16 Nov 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Michael G. Costello, Attorney-in-Fact for Raymond D. Pratt

Key filing fact

Raymond Dennis Pratt filed Form 4 for ROCKWELL MEDICAL, INC. (RMTI) on 03 Jun 2021.

Key facts

  • This page summarizes Raymond Dennis Pratt's Form 4 filing for ROCKWELL MEDICAL, INC. (RMTI).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 03 Jun 2021, 16:49.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RMTI transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
$0
Shares
+112,500
Change %
Price
$0.000000
Shares after
112,500
Date
03 May 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
112,500
Exercise price
$0.9400
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Stock options vest in two equal installments on the second and fourth anniversaries of May 3, 2021, subject to the Reporting Person's continued employment with the Issuer.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .